Page 15 - <>期刊 v2
P. 15

15
            Back                                                      ID D N U  |  iddnu@suntrap.com   |   www.suntrap.com




           Suntrap’s research team found that LeSoleil-T exerts ef-  quelae  caused  by  SARS-CoV-2  infection  include  ner-
           fects against SARS-CoV-2 through directly inhibition of   vous  system  damage,  pneumonia-induced  lung  fibro-
           the activity of TMPRSS2 and M  (also known as 3CL ).   sis,  cardiomyocyte  damage,  liver  and  kidney  damage.
                                                  pro
                                  pro
           As known, TMPRSS2 and M  are involved in SARS-CoV-2   In response to the nervous system damage caused by
                               pro
           replication and infection. For one thing, LeSoleil-T inhib-  SARS-CoV-2, LeSoleil-T showed neuroprotective effects
           its the activation of spike protein by TMPRSS2 and blocks   by regulating the expression of related proteins and re-
           the entry of the SARS-CoV-2 virus into the host cell. For   ducing the stress response. Detailed mechanisms are as
           another, it inhibits the M  of SARS-CoV-2 to suppress   follows: (1) It can reduce inflammatory to prevent cell
                              pro
           its  replication.  In  addition,  M   exists  in  various  coro-  damage and protect neurons; (2) LeSoleil-T can activate
                                 pro
           naviruses, which contribute to the broad-spectrum an-  NF-κB (Nuclear factor kappa B) to inhibit the inflamma-
           ti-coronavirus characteristic of LeSoleil-T by its inhibition   tion of microglia and the proliferation of microglia and
           of M  protein.                                 astrocytes to protect neurons; (3) LeSoleil-T can protect
              pro
                                                          neurons by inhibiting the expression of c-fos and c-jun,
           According  to  clinical  investigations,  upon  SARS-CoV-2
                                                          and regulating the expression of Bax (pro apoptotic fac-
           infection,  the  levels  of  the  neutrophil  count,  D-dimer,
                                                          tor), Bcl-2 (inhibitor of apoptosis) and caspase-3 (termi-
           blood  urea  and  creatinine  in  patients  will  increase
                                                          nal shear enzyme of apoptosis); and (4) LeSoleil-T can
           continuously, while the count of lymphocytes will con-
                                                          reconstruct the expression of Akt and pAkt in the cere-
           tinue  to  decline  until  death.  Suntrap  team  found  that
                                                          bral cortex, to maintain the levels of Akt and pAkt, and
           LeSoleil-T  could  eliminate  inflammation  induced  by
                                                          to promote neuronal survival.
           SARS-CoV-2 infection. The anti-inflammatory effects of
           LeSoleil-T are mainly to inhibit proinflammatory factor   In terms of pulmonary fibrosis caused by COVID-19, the
           expression and reduce oxidative stress responses. Firstly,   Suntrap  research  team  uncovered  that  LeSoleil-T  can
           LeSoleil-T can inhibit neutrophil aggregation to reduce   reduce the protein expression of iNOS (Inducible nitric
           the production of 4-HNE (4-hydroxynonenal) by oxida-  oxide synthase) in vivo and in vitro, resulting in reducing
           tive stress response, which leads to the reduction of the   the combination of NO and free radicals to form RNS, the
           lipid  peroxidation  end-product  formation,  and  finally,   stress reaction of the nitro, lung injury, and pulmonary
           contribute to its anti-inflammatory activity. Secondly, Le-  fibrosis.  Besides,  LeSoleil-T  can  inhibit  TGF-β1-mediat-
           Soleil-T directly inhibits the expression of proinflamma-  ed  EMT  (Epithelial-mesenchymal  transition)  signaling
           tory factors (e.g., Tnf-α, IL-1β, IL-6, Mcp-1, Mcp-2, and   pathway and reduce the phosphorylation of SMAD2/3,
           Mip-1α). Finally, it activates the interactions among PGC-  decrease ERK1/2 (extracellular signal-regulated kinase)
           1α (Peroxisome proliferator-activated receptor-γ coacti-  and activate the SMAD signal, the protein expression of
           vator), Nrf1 (Nuclear Respiratory Factor 1) and Nrf2 (Nu-  Coll and Timp, upregulate the expression of MMP (ma-
           clear Respiratory Factor 2) to regulate the mitochondrial   trix metalloproteinase), reduce the expression of ECM
           synthesis, respiration, and various antioxidant enzymes.   (extracellular matrix), prevent the ECM from accumulat-
           Meanwhile,  the  Nrf2/ARE  (antioxidant  response  ele-  ing excessively, reduce myofibroblast formation, repair
           ment) complex scavenges free radicals by regulating the   the damaged tissue, delay and reverse pulmonary fibro-
           expression of HO-1 (heme oxygenase-1).         sis.

           According  to  the  clinical  studies  on  COVID-19,  the  se-  Based on the clinical symptoms and pathogenic mecha-
   10   11   12   13   14   15   16   17   18   19   20